| Ethical Evaluation of the Concept of Soft Power and Related Medical Terminology in the COVID-19 Pandemic | Çağatay ÜSTÜN,Seçil ÖZÇİFTÇİ | 345–352 |
| Dietary Supplements and COVID-19 | Çağlayan Merve AYAZ, Mustafa CANKURTARAN, Burcu Balam DOĞU, Meltem Gülhan HALİL, Serdar CEYLAN, Didem KARADUMAN | 353–360 |
| What is the Effectiveness of Current COVID-19 Vaccines Against SARS-CoV-2 Variants? What to Know About the Need for Third Doses | Serhat ÜNAL, Leyla İpek RUDVAN AL, Meliha Çağla SÖNMEZER | 361–368 |
| The Role of Statins in Sepsis | Cansu GÖNCÜOĞLU,Hafsa Nur ÇETİNADAM,Kutay DEMİRKAN,Serhat ÜNAL | 369–377 |
| Comparison of Mouthwash and Naso-Oropharyngeal Swab Samples in the Diagnosis of COVID-19 | Hande TOPTAN, Mehmet KÖROĞLU, Elif KÖSE, Ertuğrul GÜÇLÜ, Oğuz KARABAY | 378–383 |
| COVID-19 Seroprevalance in a University Hospital Health Workers | Bahadır FEYZİOĞLU, Esma KEPENEK KURT, İbrahim ERAYMAN, Havva KAYA, Mehmet ÖZDEMİR, Gökçe Kader ARSLAN | 384–391 |
| Assessment of COVID-19 Contact Healthcare Workers at Manisa Celal Bayar University Hospital | Pınar ERBAY DÜNDAR,Nesibe Efruz ŞEN GÜNDOĞAN,Hülya ERTEN,Gülizar DENİZ,Yunus ÖZKAYA | 392–400 |
| Clinical Classification of SARS-CoV-2 Positive Patients; Evaluation of Laboratory and Radiological Findings | Gülden ERSÖZ, Yüksel BALCI, Seda TEZCAN ÜLGER, Harun GÜLBUDAK, Mehmet Burak Yavuz ÇİMEN, Nuran DELİALİOĞLU, Mukadder ÇALIKOĞLU, Şinasi KARVAR, Yusuf GÖRGÜLÜ, Gamze YAPICI, Gönül ASLAN, Asena Ayça ÖZDEMİR | 401–409 |
| Same Virus, Different Course: the Relationship Between Monocyte Chemoattractant Protein-1 and Surfactant Protein-A Levels and Clinical Course and Prognosis of COVID-19 | Ferhan KERGET, Buğra KERGET, Mehtap Hülya ASLAN, Sibel İBA YILMAZ, Ömer KARAŞAHİN, Ahmet KIZILTUNÇ | 410–418 |
| Scrutiny of Symptoms After 30 Days in Patients With COVID-19 Diagnosis | Oğuz KARABAY,Aylin ÇALICA UTKU,Aslı VATAN,Gökçen BUDAK,Ertuğrul GÜÇLÜ | 419–425 |
| Does the Hitit Index Work in the Differential Diagnosis of CCHF and COVID-19 with Non-Specific Findings? |